Ximing Li

机构：University Health Network, Tianjin University, University of Toronto, Princess Margaret Cancer Centre, China National Pharmaceutical Group Corporation (China), Shanghai Pulmonary Hospital, Shanghai East Hospital, Second Hospital of Tianjin Medical University, Tianjin Chest Hospital, Tianjin Medical University · ORCID：0000-0003-4287-3152

发表论文 88 篇 · 总被引 829 次 · h-index 15

代表论文

• Empagliflozin protects against heart failure with preserved ejection fraction partly by inhibiting the senescence-associated STAT1–STING axis (2024 · Cardiovascular Diabetology · 被引 35)
• In-Hospital Changes in the Red Blood Cell Distribution Width and Mortality in Critically Ill Patients with Heart Failure (2023 · ESC Heart Failure · 被引 14)
• Right ventricular-arterial uncoupling as an independent prognostic factor in acute heart failure with preserved ejection fraction accompanied with coronary artery disease (2023 · Chinese Medical Journal · 被引 11)
• An inflammatory state defines a high-risk T-lineage acute lymphoblastic leukemia subgroup (2025 · Science Translational Medicine · 被引 10)
• Pre-anesthetic use of butorphanol for the prevention of emergence agitation in thoracic surgery: A multicenter, randomized controlled trial (2022 · Frontiers in Medicine · 被引 7)
• Role of serum CAP1 protein in the diagnosis of patients with first-time acute myocardial infarction (2023 · Medicine · 被引 4)